- Independent Data Monitoring Committees: Review of Current Guidelines
-
Lee BR, Lee KE
- KMID: 2358070
- Korean J Clin Pharm.
- 2016 Jun;26(2):181-186.
- doi: 10.0000/kjcp.2016.26.2.181
BACKGROUND: There has been on increasing emphasis on the importance of monitoring the safety of participants in a clinical trial to protect patients and maintain the integrity of the trial.... -
- CITED
-
- Close
- SHARE
-
- Close
- Results from the safety interim analysis of the adjuvant chemoradiotherapy in stomach tumors 2 trial: a multicenter, randomized phase III clinical trial
-
Park SH, Lee J, Sohn TS, Lim DH, Kim KM, An JY, Choi MG, Lee JH, Bae JM, Kim S, Lee SJ, Kim ST, Park JO, Park YS, Lim HY, Kang WK
- KMID: 2469525
- Precis Future Med.
- 2019 Mar;3(1):24-29.
- doi: 10.23838/pfm.2018.00177
PURPOSE: The Adjuvant chemoRadioTherapy In Stomach Tumors 2 (ARTIST 2) trial was conducted to compare the efficacy between adjuvant chemotherapy regimens and chemoradiotherapy in D2-resected, node-positive, stage 2 or 3... -
- CITED
-
- Close
- SHARE
-
- Close
